BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 34 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,624 | -54.2% | 10,981 | 0.0% | 0.00% | – |
Q4 2022 | $7,906 | -39.2% | 10,981 | 0.0% | 0.00% | – |
Q3 2022 | $13,000 | 0.0% | 10,981 | 0.0% | 0.00% | – |
Q2 2022 | $13,000 | -45.8% | 10,981 | 0.0% | 0.00% | – |
Q1 2022 | $24,000 | +50.0% | 10,981 | 0.0% | 0.00% | – |
Q4 2021 | $16,000 | -50.0% | 10,981 | 0.0% | 0.00% | – |
Q3 2021 | $32,000 | -11.1% | 10,981 | 0.0% | 0.00% | – |
Q2 2021 | $36,000 | -12.2% | 10,981 | 0.0% | 0.00% | – |
Q1 2021 | $41,000 | +5.1% | 10,981 | 0.0% | 0.00% | – |
Q4 2020 | $39,000 | – | 10,981 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 500,000 | $1,881,000 | 0.06% |
AJU IB Investment Co., Ltd. | 25,651 | $96,000 | 0.04% |
BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $199,000 | 0.01% |
Baker Brothers Advisors | 249,123 | $937,000 | 0.00% |
SHUFRO ROSE & CO LLC | 12,941 | $49,000 | 0.00% |
Squarepoint Ops LLC | 27,915 | $105,000 | 0.00% |
Tekla Capital Management LLC | 6,000 | $23,000 | 0.00% |
Orion Capital Management LLC | 500 | $2,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 13,300 | $50,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 26 | $0 | 0.00% |